|
VAMP3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.426500E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.32779999999044E-05 |
| Normal-vs-Stage2 |
4.700600E-01 |
| Normal-vs-Stage3 |
3.014400E-01 |
| Normal-vs-Stage4 |
3.760200E-02 |
| Stage1-vs-Stage2 |
7.494000E-02 |
| Stage1-vs-Stage3 |
1.81509999996887E-06 |
| Stage1-vs-Stage4 |
1.65310000022068E-07 |
| Stage2-vs-Stage3 |
1.871610E-01 |
| Stage2-vs-Stage4 |
4.441500E-02 |
| Stage3-vs-Stage4 |
2.780600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.490200E-02 |
| Normal-vs-AfricanAmerican |
4.488000E-01 |
| Normal-vs-Asian |
4.803200E-01 |
| Caucasian-vs-AfricanAmerican |
6.088000E-02 |
| Caucasian-vs-Asian |
6.948400E-01 |
| AfricanAmerican-vs-Asian |
2.385600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.886400E-01 |
| Normal-vs-Female |
1.683540E-02 |
| Male-vs-Female |
1.104760E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.279200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.051910E-02 |
| Normal-vs-Age(61-80Yrs) |
4.855200E-01 |
| Normal-vs-Age(81-100Yrs) |
6.067800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.413400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.689800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.320600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.376200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.210570E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.954600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.283800E-03 |
| Normal-vs-Grade 2 |
2.68289999993954E-07 |
| Normal-vs-Grade 3 |
4.019400E-01 |
| Normal-vs-Grade 4 |
9.154100E-04 |
| Grade 1-vs-Grade 2 |
1.308770E-01 |
| Grade 1-vs-Grade 3 |
7.58750000000585E-05 |
| Grade 1-vs-Grade 4 |
3.37460000054968E-07 |
| Grade 2-vs-Grade 3 |
6.99439950402336E-10 |
| Grade 2-vs-Grade 4 |
9.97091298415853E-13 |
| Grade 3-vs-Grade 4 |
7.560000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.94939997267119E-09 |
| Normal-vs-ccB subtype |
3.489400E-01 |
| ccA subtype-vs-ccB subtype |
1.27450050513289E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.702020E-01 |
| Normal-vs-N1 |
7.520600E-01 |
| N0-vs-N1 |
4.021800E-01 |
|
|
